Author:
Pratt Craig M.,Roy Denis,Torp-Pedersen Christian,Wyse D. George,Toft Egon,Juul-Moller Steen,Retyk Enrique,Drenning David Humphrey
Subject
Cardiology and Cardiovascular Medicine
Reference7 articles.
1. The mechanism of atrial antiarrhythmic action of RSD1235;Fedida;J Cardiovasc Electrophysiol,2005
2. RSD1235 selectively prolongs atrial refractoriness and terminates AF in dogs with electrically remodelled atria;Beatch;Pacing Clin Electrophysiol,2002
3. The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans;Dorian;J Cardiovasc Pharmacol,2007
4. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation;Roy;J Am Coll Cardiol,2004
5. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial;Roy;Circulation,2008
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献